[go: up one dir, main page]

CS182991A3 - Aminobenzodiazepines, process of their preparation and medicaments based thereon - Google Patents

Aminobenzodiazepines, process of their preparation and medicaments based thereon Download PDF

Info

Publication number
CS182991A3
CS182991A3 CS911829A CS182991A CS182991A3 CS 182991 A3 CS182991 A3 CS 182991A3 CS 911829 A CS911829 A CS 911829A CS 182991 A CS182991 A CS 182991A CS 182991 A3 CS182991 A3 CS 182991A3
Authority
CS
Czechoslovakia
Prior art keywords
infections
hiv
formula
compound
cells
Prior art date
Application number
CS911829A
Other languages
Czech (cs)
English (en)
Inventor
Anne Roberte Bellemin
James Valentine Early
Ming-Chu Hsu
Steve Yik-Kai Tam
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CS182991A3 publication Critical patent/CS182991A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CS911829A 1990-06-18 1991-06-14 Aminobenzodiazepines, process of their preparation and medicaments based thereon CS182991A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/539,500 US5141735A (en) 1990-06-18 1990-06-18 Substituted amino-benzodiazepines having anitviral activity

Publications (1)

Publication Number Publication Date
CS182991A3 true CS182991A3 (en) 1992-04-15

Family

ID=24151485

Family Applications (1)

Application Number Title Priority Date Filing Date
CS911829A CS182991A3 (en) 1990-06-18 1991-06-14 Aminobenzodiazepines, process of their preparation and medicaments based thereon

Country Status (21)

Country Link
US (1) US5141735A (xx)
EP (1) EP0462522A1 (xx)
JP (1) JPH04230280A (xx)
KR (1) KR920000746A (xx)
CN (1) CN1057462A (xx)
AU (1) AU7846991A (xx)
BR (1) BR9102489A (xx)
CA (1) CA2044694A1 (xx)
CS (1) CS182991A3 (xx)
FI (1) FI912927A (xx)
HU (1) HUT58069A (xx)
IE (1) IE912061A1 (xx)
IL (1) IL98499A0 (xx)
IS (1) IS3718A7 (xx)
LT (1) LTIP863A (xx)
MC (1) MC2263A1 (xx)
MX (1) MX26267A (xx)
NO (1) NO912346L (xx)
NZ (1) NZ238552A (xx)
PT (1) PT98007A (xx)
ZA (1) ZA914202B (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888992A (en) * 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
JPH07504654A (ja) * 1992-03-11 1995-05-25 ナルヘックス　リミテッド オキソ及びヒドロキシ置換炭化水素のアミン誘導体
US6071895A (en) * 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
ATE253050T1 (de) 1992-03-11 2003-11-15 Narhex Ltd Aminderivate von oxo- und hydroxy- substituierten kohlenwasserstoffen
SI9300288A (sl) * 1992-06-16 1993-12-31 Hoffmann La Roche Benzodiazepini
JPH08502966A (ja) * 1992-10-23 1996-04-02 ユニバーシティー・オブ・マサチューセッツ・メディカル・センター Ｒｎａ／リガンド結合の低分子抑制
US5939430A (en) * 1993-02-22 1999-08-17 Merrell Pharmaceuticals Inc. Combinations of retroviral inhibitors
US5578573A (en) * 1995-01-20 1996-11-26 Houghten Pharmaceuticals, Inc. Viral integrase inhibiting peptides
ATE430477T1 (de) * 1996-10-16 2009-05-15 Napo Pharmaceuticals Inc Enteral-formulierungen von proanthocyanidzusammensetzungen gegen diarrhöe
US7015212B1 (en) 1999-05-12 2006-03-21 The United States Of America As Represented By The Department Of Health And Human Services Thiazepine inhibitors of HIV-1 integrase
GB0015904D0 (en) 2000-06-28 2000-08-23 Hoffmann La Roche Inhibitors of HPV E1 helicase enzyme
US20030129162A1 (en) * 2000-09-12 2003-07-10 Lau Allan S. Compositions comprising mixtures of therapeutic proteins and methods of producing the same
US20020150541A1 (en) * 2000-09-12 2002-10-17 Gene Trol Biotherapeutics, Inc. Compositions comprising mixtures of therapeutic proteins and methods of producing the same
US20020150552A1 (en) * 2000-09-12 2002-10-17 Lau Allan S. Compositions comprising mixtures of therapeutic proteins and methods of producing the same
JP2005089298A (ja) * 2001-09-18 2005-04-07 Japan Tobacco Inc ナフタレン化合物及びその医薬用途
BR0213093A (pt) * 2001-10-05 2005-03-15 Intermune Inc Métodos para tratamento de fibrose hepática e de infecção pelo vìrus da hepatite c
US20050148512A1 (en) * 2003-11-10 2005-07-07 Angiotech International Ag Medical implants and fibrosis-inducing agents
KR100652975B1 (ko) * 2005-03-17 2006-12-01 유해일 옥수숫대 반화학 기계펄프의 제조방법
US9446048B2 (en) 2011-03-17 2016-09-20 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods for treating leukemia and disorders mediated by CBFβ and RUNX1 proteins
CN109906220A (zh) * 2016-11-01 2019-06-18 豪夫迈·罗氏有限公司 用于治疗cns相关疾病的1,3-二氢-1,4-苯并二氮杂*-2-硫酮化合物
WO2018093797A1 (en) 2016-11-15 2018-05-24 The Schepens Eye Research Institute, Inc. Compositions and methods for the treatment of aberrant angiogenesis
US11583497B2 (en) 2017-11-14 2023-02-21 The Schepens Eye Research Institute, Inc. Nano-emulsion of CBFß-RUNX1 inhibitor for ocular drug delivery
EP3710008A4 (en) 2017-11-14 2021-08-25 The Schepens Eye Research Institute, Inc. RUNX1 INHIBITION FOR THE TREATMENT OF PROLIFERATIVE VITREORETINOPATHY AND DISEASES ASSOCIATED WITH EPITHELIAL-MESENCHYMAL TRANSITION

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3267110A (en) * 1960-06-03 1966-08-16 Smith Kline French Lab Trifluoromethyl substituted o-aminophenyl ketones
NL279830A (xx) * 1961-06-20
NL126389C (xx) * 1962-07-10
US3330481A (en) * 1965-03-18 1967-07-11 Filtra Inc Dispersant dispenser of an absorbent or adsorbent material
CH502354A (de) * 1967-03-08 1971-01-31 Hoffmann La Roche Verfahren zur Herstellung von Benzodiazepin-Derivaten
JPS4843755B1 (xx) * 1969-06-26 1973-12-20
ZA698792B (en) * 1968-12-30 1971-03-31 Fujisawa Pharmaceutical Co Novel antibiotic and derivatives and production thereof
US3778433A (en) * 1969-04-18 1973-12-11 Sumitomo Chemical Co Process for producing benzodiazepine derivatives
US3954728A (en) * 1972-07-13 1976-05-04 Hoffman-La Roche Inc. Preparation of triazolo benzodiazepines and novel compounds
DE3619202A1 (de) * 1986-06-07 1987-12-10 Merz & Co Gmbh & Co Verwendung von avaron und avarol sowie von derivaten davon zur bekaempfung von aids und arc
US4788181A (en) * 1986-09-29 1988-11-29 The United States Of America As Represented By The Department Of Health And Human Services 5-substituted-2',3'-dideoxycytidine compounds with anti-HTLV-III activity
GB8806449D0 (en) * 1988-03-18 1988-04-20 Janssen Pharmaceutica Nv Antiviral hexahydroimiazo(1 4)benzodiazepin-2-ones

Also Published As

Publication number Publication date
IS3718A7 (is) 1991-12-19
EP0462522A1 (en) 1991-12-27
US5141735A (en) 1992-08-25
FI912927A0 (fi) 1991-06-17
CA2044694A1 (en) 1991-12-19
NO912346L (no) 1991-12-19
BR9102489A (pt) 1992-01-21
IE912061A1 (en) 1991-12-18
FI912927A (fi) 1991-12-19
HU912005D0 (en) 1991-12-30
IL98499A0 (en) 1992-07-15
JPH04230280A (ja) 1992-08-19
MX26267A (es) 1993-09-01
NO912346D0 (no) 1991-06-17
MC2263A1 (fr) 1993-04-26
NZ238552A (en) 1993-08-26
CN1057462A (zh) 1992-01-01
AU7846991A (en) 1992-01-02
LTIP863A (en) 1995-03-27
KR920000746A (ko) 1992-01-29
HUT58069A (en) 1992-01-28
PT98007A (pt) 1992-03-31
ZA914202B (en) 1992-03-25

Similar Documents

Publication Publication Date Title
CS182991A3 (en) Aminobenzodiazepines, process of their preparation and medicaments based thereon
NO314936B1 (no) 4,4-disubstituerte-3,4-dihydro-2(1H)-kinazolinoner, farmasöytiske sammensetninger, preparater og farmasöytiske sett til behandling av HIV-infeksjon, samt anvendelse av bestemte kinazolinoner for fremstilling av etfarmasöytisk preparat
SK279262B6 (sk) Protivírusová zmes, farmaceutický prostriedok s je
JPH04305578A (ja) ベンゾジアゼピン、その製造法、及び薬剤としての利用
US5026726A (en) Gossylic iminolactones and gossylic lactones and their anti-viral activities
CN100450487C (zh) 作为细胞增殖拮抗剂和细胞分化诱导剂的逆转录酶非核苷抑制剂
CZ115893A3 (en) Benzodiazepines, process for preparing thereof and medicaments based thereon
Halliday et al. Inhibition of human immunodeficiency virus replication by the sulfonated stilbene dye resobene
IE903879A1 (en) Use of a benzodiazepine and a phenylpyrrylketone derivative
CZ372792A3 (en) Pyrrolylbenzodiazepinones, processes of their preparation and medicaments based thereon
US5932570A (en) 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as HIV protease inhibitors
JP2911956B2 (ja) ５，１１―ジヒドロ―６Ｈ―ピリド［２，３―ｂ］［１，４］ベンゾジアゼピン―６―オン及び―チオン並びに該化合物のＡＩＤＳの予防又は治療における使用法
EP0586632A1 (en) Benzodiazepinones and medicines containing them
US6451999B2 (en) 1-(3-aminoindazol-5-yl)-3-butyl-cyclic urea useful as a HIV protease inhibitor
EP0937067B1 (en) 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as hiv protease inhibitors
US6313110B1 (en) Substituted 2H-1,3-diazapin-2-one useful as an HIV protease inhibitor
US20050026910A1 (en) Method of treating viral diseases
SK122996A3 (en) Novel crystal forms of 1-£5-methanesulfonamidoindolyl-2- -carbonyl|-4-£3-(1-methylethylamino)-2-pyridinyl|piperazine
SI9720071A (sl) 1-(3-aminoindazol-5-il)-3-butil-ciklična sečnina, uporabna kot inhibitor proteaze HIV
JP2003503455A (ja) 抗ウイルス治療
JPH06172365A (ja) １０−チアイソアロキサジン誘導体およびその用途
ITMI950811A1 (it) Pirrolobenzotiadiazepine e relativo processo di produzione ed impiego nella terapia delle infezioni da virus dell'aids
HRP970586A2 (en) 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as hiv protease inhibitors